HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological characterization of AR-M1000390 at human delta opioid receptors.

Abstract
We investigated the pharmacological properties of a newly synthesised delta agonist AR-M1000390, derived from SNC-80 ((+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethyl-benzamide), in the neuroblastoma cell line SK-N-BE expressing only human delta-opioid receptors. Binding and functional experiments showed a weak affinity (K(i) = 106 +/- 34 nM) correlated with a weak potency (EC(50) = 111 +/- 31 nM) to inhibit the forskolin-stimulated cAMP accumulation. Sustained activation of opioid receptors in the presence of the maximal inhibitory concentration of AR-M1000390 produced a rapid and strong desensitization. In order to examine the contribution of internalization and down-regulation in the desensitization processes, binding and functional experiments were conducted in the presence or in the absence of hypertonic sucrose solution to block clathrin-dependent opioid receptor endocytosis. We observed both the inability of AR-M1000390 to down-regulate opioid receptors and the absence of any effect of sucrose on desensitization. The lack of delta-opioid receptor internalization by AR-M1000390 was further corroborated by confocal microscopy using antibodies directed either against the endogenous delta-opioid receptors or the FLAG-tagged delta-opioid receptors stably expressed in the SK-N-BE cells. These data suggest that uncoupling rather than internalization is responsible for delta-opioid receptors desensitization by AR-M1000390.
AuthorsNicolas Marie, Gérard Landemore, Claire Debout, Philippe Jauzac, Stéphane Allouche
JournalLife sciences (Life Sci) Vol. 73 Issue 13 Pg. 1691-704 (Aug 15 2003) ISSN: 0024-3205 [Print] Netherlands
PMID12875901 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzamides
  • N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide
  • Narcotic Antagonists
  • Piperazines
  • Piperidines
  • Receptors, Opioid, delta
  • 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
  • Sucrose
  • Adenylyl Cyclases
Topics
  • Adenylyl Cyclases (metabolism)
  • Benzamides (pharmacology)
  • Down-Regulation
  • Endocytosis (drug effects)
  • Humans
  • Microscopy, Confocal
  • Narcotic Antagonists (pharmacology)
  • Neuroblastoma (metabolism, pathology)
  • Piperazines
  • Piperidines (pharmacology)
  • Receptors, Opioid, delta (agonists, immunology, metabolism)
  • Signal Transduction
  • Sucrose (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: